Breaking News
Sort by:
Top Post
Google Cloud Launches AI-powered Solutions to Safely Accelerate Drug Discovery and Precision Medicine
Google Cloud has announced two new AI-powered life sciences solutions to accelerate drug discovery and […]
Biologics License Application for Lecanemab Designated for Priority Review by China National Medical Products Administration
Eisai and Biogen announced today that the Biologics License Application (BLA) for lecanemab, an investigational […]
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib
Oscotec announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of […]
Nektar Therapeutics Announces Phase 2 Topline Data for Rezpegaldesleukin in Patients with Systemic Lupus Erythematosus
Nektar Therapeutics today announced topline data from a Phase 2 randomized, double-blind, placebo-controlled study of […]
COVID-19 Rapid Antigen Self-Test, COVI-Go, receives FDA Emergency Use Authorization for Home Use
Mologic, the US subsidiary of Global Access Diagnostics (GADx), a leading developer of lateral flow […]
Shuttle Pharmaceuticals Expands Laboratory Space to Advance Drug Development Pipeline and Diagnostic Capabilities
Shuttle Pharmaceuticals, a discovery and development stage specialty pharmaceutical company focused on improving the outcomes […]
FDA Accepts Orasis Pharmaceuticals' New Drug Application for CSF-1 for the Treatment of Presbyopia
Orasis Pharmaceuticals, an emerging ophthalmic pharmaceutical company focused on developing a unique eye drop to […]
Pharming announces First Patient Enrolled in Pediatric Clinical Trial of leniolisib
Pharming Group announces that the first patient has been enrolled in its Phase III clinical […]
Azafaros Receives Additional Regulatory Designations for AZ-3102 from FDA, EMA and MHRA
Azafaros today announced its progress in ongoing interactions with Health Authorities regarding its lead drug […]
Astellas Provides Update on Fezolinetant New Drug Application in U.S.
Astellas Pharma has announced the US Food and Drug Administration (FDA) notified the company that […]
Trodelvy Demonstrates Positive Efficacy Treating Both Platinum-Ineligible and Rapidly Progressing, Post-Platinum Metastatic Urothelial Cancer
Gilead Sciences has announced new and updated positive results from three cohorts of the Phase 2 […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more